BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23555812)

  • 21. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
    Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
    Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus.
    Su H; Ye X; Freed DC; Li L; Ku Z; Xiong W; Gao P; Liu X; Montgomery D; Xu W; Espeseth AS; Wang D; Ma N; Fu TM; Zhang N; An Z
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
    Revello MG; Gerna G
    Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection.
    Boppana SB; Britt WJ
    J Infect Dis; 1995 May; 171(5):1115-21. PubMed ID: 7751685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenesis of Human Cytomegalovirus Glycoprotein L Disproportionately Disrupts gH/gL/gO over gH/gL/pUL128-131.
    Schultz EP; Yu Q; Stegmann C; Day LZ; Lanchy JM; Ryckman BJ
    J Virol; 2021 Aug; 95(17):e0061221. PubMed ID: 34132577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
    Chiuppesi F; Kaltcheva T; Meng Z; Barry PA; Diamond DJ; Wussow F
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes.
    Ciferri C; Chandramouli S; Donnarumma D; Nikitin PA; Cianfrocco MA; Gerrein R; Feire AL; Barnett SW; Lilja AE; Rappuoli R; Norais N; Settembre EC; Carfi A
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1767-72. PubMed ID: 25624487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
    Choi KY; El-Hamdi NS; McGregor A
    J Gen Virol; 2020 Apr; 101(4):426-439. PubMed ID: 32068527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.
    Liu J; Jardetzky TS; Chin AL; Johnson DC; Vanarsdall AL
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.
    Day LZ; Stegmann C; Schultz EP; Lanchy JM; Yu Q; Ryckman BJ
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
    Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.
    Ciferri C; Chandramouli S; Leitner A; Donnarumma D; Cianfrocco MA; Gerrein R; Friedrich K; Aggarwal Y; Palladino G; Aebersold R; Norais N; Settembre EC; Carfi A
    PLoS Pathog; 2015 Oct; 11(10):e1005230. PubMed ID: 26485028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.
    Gerna G; Lilleri D; Fornara C; Bruno F; Gabanti E; Cane I; Furione M; Revello MG
    J Gen Virol; 2015 Feb; 96(Pt 2):360-369. PubMed ID: 25316796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.
    Zydek M; Petitt M; Fang-Hoover J; Adler B; Kauvar LM; Pereira L; Tabata T
    Viruses; 2014 Mar; 6(3):1346-64. PubMed ID: 24651029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.
    Furione M; Rognoni V; Sarasini A; Zavattoni M; Lilleri D; Gerna G; Revello MG
    J Med Virol; 2013 Nov; 85(11):1960-7. PubMed ID: 23893782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.
    Nguyen CC; Kamil JP
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30544948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.
    Nozawa N; Fang-Hoover J; Tabata T; Maidji E; Pereira L
    J Clin Virol; 2009 Dec; 46 Suppl 4(Suppl 4):S58-63. PubMed ID: 19854676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.